Independent Contractor at Design Renaissance, Founder at Architecture and Anthropology Curiosity Collaborative, Freelance writer at textbroker.com
Location:
Denver, Colorado
Industry:
Architecture & Planning
Work:
Design Renaissance since Aug 2012
Independent Contractor
Architecture and Anthropology Curiosity Collaborative since 2009
Founder
textbroker.com since Aug 2009
Freelance writer
Christy Sports - Frisco Nov 2010 - Apr 2012
Rental and Retail Tech
Cheley Colorado Camps - Estes Park May 2011 - Oct 2011
Mountain Biking Counselor
Education:
California Polytechnic State University-San Luis Obispo 2004 - 2009
Bachelor of Architecture
Colorado Mountain College 2011 - 2011
Danish Institute for Study Abroad 2007 - 2008
Skills:
Revit Adobe Creative Suite Drawing Research Architectural Design Urban Design Design Research Sustainable Design AutoCAD Architecture Architectural Drawings SketchUp Cheetah 3D Writing Model Building Woodworking
Interests:
Traveling, the mountains, architecture, urbanism, writing, reading, photography, film, anthropology
Honor & Awards:
R.L. Graves, Jr. Scholarship
Dean's List, Fall 2004, Fall 2008, Winter 2009, Spring 2009
President's Honors List, Spring 2009
Massachusetts General Hospital Cancer Center 32 Fruit St FL 7-9, Boston, MA 02114 617-724-4000 (phone), 617-726-1949 (fax)
Education:
Medical School Univ of the Witwatersrand, Med Sch, Johannesburg, So Africa Graduated: 1978
Conditions:
Malignant Neoplasm of Female Breast
Languages:
English Spanish
Description:
Dr. Goss graduated from the Univ of the Witwatersrand, Med Sch, Johannesburg, So Africa in 1978. He works in Boston, MA and specializes in Medical Oncology. Dr. Goss is affiliated with Massachusetts General Hospital.
While many women with early-stage breast cancer live for a long time, they face an indefinite risk of relapse, said lead study author, Paul Goss, director of breast cancer research at Massachusetts General Hospital. He said the new research "provides direction for many patients and their doctors,
to galvanize everybody to take action... Cancer is going to be the number one threat and we believe it is very wise to invest more and distribute the budget and resources equitably across all the populations of a country," lead researcher Paul Goss of Harvard Medical School told a press conference.
Paul Goss, professor of medicine at Harvard Medical School in Boston, who led the research team, said: "More widespread adoption of lifestyles similar to those in developed countries will lead to a rapidly growing number of patients with cancer, a cost burden for which Latin American countries are n
Date: Apr 25, 2013
Category: Health
Source: Google
Breast cancer drug more effective when taken for 10 years: study
"For postmenopausal women, the data still remain much stronger at this point for a switch to an aromatase inhibitor," said that study's leader, Dr. Paul Goss of Massachusetts General Hospital. He has been a paid speaker for a company that makes one of those drugs.
Date: Dec 05, 2012
Category: Health
Source: Google
Pfizer's Breast-Cancer Drug Worsens Bone Loss in Older Women
vious studies have shown that women treated for as much as five years with so-called aromatase inhibitors -- the class of drugs including Aromasin -- have no increase in their risk of fractures when compared with placebo or no treatment, said Paul Goss, a professor of medicine at Harvard Medical Sch
Date: Feb 06, 2012
Category: Health
Source: Google
Drug slashes cases of breast cancer in high-risk groups: Trial
Dr. Paul Goss, director of Breast Cancer Research at Massachusetts General Hospital, led the study and said one of the main benefits of the drug compared to other options are the reduction of serious side effects.
Date: Jun 05, 2011
Category: Health
Source: Google
Drug that treats breast cancer found to prevent it too
"We proved that exemestane (Aromasin) reduced the risk of invasive breast cancer by 65%," said lead author Dr. Paul Goss, who is a breast cancer specialist at Boston's Massachusetts General Hospital. Goss presented his research at the annual conference of the American Society of Clinical Oncology. T
"There's a very safe therapy that looks highly effective in preventing breast cancer," Dr. Paul Goss, professor of medicine at Harvard and Massachusetts General Hospital, said at a news conference at the annual meeting of the American Society of Clinical Oncology. He was the lead investigator in the